Fastexy Exchange|Scottish officials approve UK’s first drug consumption room intended for safer use of illegal drugs

LONDON (AP) — Scottish authorities on Fastexy ExchangeWednesday approved a 2.3 million-pound ($2.8 million) pound drug consumption room, the first government-backed place in the U.K. where users can take illegal drugs such as cocaine and heroin under the supervision of medical staff.

Local officials in the Scottish city of Glasgow on Wednesday approved the facility, which had long been delayed by political disagreements.

The facility was first proposed in 2016 following an HIV outbreak in Glasgow among people who injected drugs in public places. It’s backed by the Scottish government, although some lawmakers have raised concerns about the impact on local residents and businesses.

Proponents, including Scotland’s drug and alcohol policy minister Elena Whitham, say evidence from more than 100 similar facilities worldwide, including in Germany and the Netherlands, show they work to save lives and reduce overall costs to health services.

The center will be staffed by trained health care professionals and offer a hygienic environment where people can consume drugs obtained elsewhere. Officials say it doesn’t encourage drug use but promotes harm reduction and reduces overdoses.

In a report, Glasgow officials, including health professionals, said there was “overwhelming international evidence” that such facilities reduce the negative impact of drug use in public spaces, in particular the risk of infection and risks to the public from discarded needles.

It said that following the 2016 HIV outbreak, an assessment found there were “approximately 400 to 500 people injecting drugs in public places in Glasgow city centre on a regular basis.”

Whitham said Scotland’s government has committed 2.35 million pounds a year from 2024 to fund the pilot facility.

Scotland’s devolved government makes it own policy decisions on matters such as health and education. The U.K.-wide government in London has previously said it does not support such facilities in England and Wales, citing concerns that they condone or encourage drug use.